Grendarova: End-of-life Cancer Care
Supplementary Table 1: Distribution of decedents by 19 cancer types and associated outcomes-of-interest
Tumor / EOL_Chemo / EOL_RT / NewChemo-30 days / AnyChemo-
30 days / AnyRT-
30 days / Hospitalized Death
Total (n) / Col % / No / Yes / No / Yes / No / Yes / No / Yes / No / Yes / No / Yes
GI - colorectal+anus / 1134 / 11.5 / 1097 / 37 / 1120 / 14 / 1111 / 23 / 1060 / 74 / 1087 / 47 / 790 / 344
row% / 96.74 / 3.26 / 98.77 / 1.23 / 97.97 / 2.03 / 93.47 / 6.53 / 95.86 / 4.14 / 69.66 / 30.34
GI - hepatopancreas / 927 / 9.4 / 900 / 27 / 921 / 6 / 909 / 18 / 838 / 89 / 913 / 14 / 664 / 263
row% / 97.09 / 2.91 / 99.35 / 0.65 / 98.06 / 1.94 / 90.4 / 9.6 / 98.49 / 1.51 / 71.63 / 28.37
GI - others / 621 / 6.3 / 609 / 12 / 598 / 23 / 615 / 6 / 599 / 22 / 574 / 47 / 427 / 194
row% / 98.07 / 1.93 / 96.3 / 3.7 / 99.03 / 0.97 / 96.46 / 3.54 / 92.43 / 7.57 / 68.76 / 31.24
LUNG / 2364 / 24.0 / 2313 / 51 / 2167 / 197 / 2312 / 52 / 2263 / 101 / 1948 / 416 / 1554 / 810
row% / 97.84 / 2.16 / 91.67 / 8.33 / 97.8 / 2.2 / 95.73 / 4.27 / 82.4 / 17.6 / 65.74 / 34.26
GU - prostate / 584 / 5.9 / 575 / 9 / 564 / 20 / 579 / 5 / 566 / 18 / 542 / 42 / 396 / 188
row% / 98.46 / 1.54 / 96.58 / 3.42 / 99.14 / 0.86 / 96.92 / 3.08 / 92.81 / 7.19 / 67.81 / 32.19
GU - others / 515 / 5.2 / 506 / 9 / 492 / 23 / 508 / 7 / 494 / 21 / 462 / 53 / 321 / 194
row% / 98.25 / 1.75 / 95.53 / 4.47 / 98.64 / 1.36 / 95.92 / 4.08 / 89.71 / 10.29 / 62.33 / 37.67
Hematol - lymph-myel / 606 / 6.1 / 566 / 40 / 571 / 35 / 587 / 19 / 522 / 84 / 542 / 64 / 298 / 308
row% / 93.4 / 6.6 / 94.22 / 5.78 / 96.86 / 3.14 / 86.14 / 13.86 / 89.44 / 10.56 / 49.17 / 50.83
Hematol - leukemias / 293 / 3.0 / 281 / 12 / 289 / 4 / 288 / 5 / 272 / 21 / 284 / 9 / 130 / 163
row% / 95.9 / 4.1 / 98.63 / 1.37 / 98.29 / 1.71 / 92.83 / 7.17 / 96.93 / 3.07 / 44.37 / 55.63
Breast / 864 / 8.8 / 818 / 46 / 830 / 34 / 834 / 30 / 784 / 80 / 776 / 88 / 585 / 279
row% / 94.68 / 5.32 / 96.06 / 3.94 / 96.53 / 3.47 / 90.74 / 9.26 / 89.81 / 10.19 / 67.71 / 32.29
Gyne / 542 / 5.5 / 517 / 25 / 528 / 14 / 517 / 25 / 492 / 50 / 513 / 29 / 357 / 185
row% / 95.39 / 4.61 / 97.42 / 2.58 / 95.39 / 4.61 / 90.77 / 9.23 / 94.65 / 5.35 / 65.87 / 34.13
CNS / 355 / 3.6 / 355 / 0 / 340 / 15 / 355 / 0 / 354 / 1 / 329 / 26 / 287 / 68
row% / 100 / 0 / 95.77 / 4.23 / 100 / 0 / 99.72 / 0.28 / 92.68 / 7.32 / 80.85 / 19.15
Head & Neck / 306 / 3.1 / 296 / 10 / 288 / 18 / 301 / 5 / 288 / 18 / 261 / 45 / 187 / 119
row% / 96.73 / 3.27 / 94.12 / 5.88 / 98.37 / 1.63 / 94.12 / 5.88 / 85.29 / 14.71 / 61.11 / 38.89
Unknown / 232 / 2.4 / 226 / 6 / 219 / 13 / 223 / 9 / 218 / 14 / 209 / 23 / 163 / 69
row% / 97.41 / 2.59 / 94.4 / 5.6 / 96.12 / 3.88 / 93.97 / 6.03 / 90.09 / 9.91 / 70.26 / 29.74
Melanoma / 192 / 1.9 / 188 / 4 / 173 / 19 / 186 / 6 / 180 / 12 / 153 / 39 / 131 / 61
row% / 97.92 / 2.08 / 90.1 / 9.9 / 96.88 / 3.13 / 93.75 / 6.25 / 79.69 / 20.31 / 68.23 / 31.77
Sarcoma / 127 / 1.3 / 124 / 3 / 118 / 9 / 122 / 5 / 119 / 8 / 112 / 15 / 91 / 36
row% / 97.64 / 2.36 / 92.91 / 7.09 / 96.06 / 3.94 / 93.7 / 6.3 / 88.19 / 11.81 / 71.65 / 28.35
Heart/pleura (mesoth) / 85 / 0.9 / 82 / 3 / 82 / 3 / 82 / 3 / 80 / 5 / 78 / 7 / 54 / 31
row% / 96.47 / 3.53 / 96.47 / 3.53 / 96.47 / 3.53 / 94.12 / 5.88 / 91.76 / 8.24 / 63.53 / 36.47
Skin - invasive / 58 / 0.6 / 58 / 0 / 52 / 6 / 58 / 0 / 57 / 1 / 46 / 12 / 41 / 17
row% / 100 / 0 / 89.66 / 10.3 / 100 / 0 / 98.28 / 1.72 / 79.31 / 20.69 / 70.69 / 29.31
Endocrine / 44 / 0.4 / 42 / 2 / 39 / 5 / 42 / 2 / 41 / 3 / 32 / 12 / 21 / 23
row% / 95.45 / 4.55 / 88.64 / 11.4 / 95.45 / 4.55 / 93.18 / 6.82 / 72.73 / 27.27 / 47.73 / 52.27
Miscellaneous / 14 / 0.1 / 14 / 0 / 14 / 0 / 14 / 0 / 14 / 0 / 14 / 0 / 11 / 3
row% / 100 / 0 / 100 / 0 / 100 / 0 / 100 / 0 / 100 / 0 / 78.57 / 21.43
Total (n) / 9863 / 100% / 9567 / 296 / 9405 / 458 / 9643 / 220 / 9241 / 622 / 8875 / 988 / 6508 / 3355